Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**ESVIFIL** is an oral renal-nutrition multivitamin product marketed by Biokindle for people with chronic kidney disease who may have restricted dietary vitamin intake. The manufacturer describes it as a tablet formulation containing eight essential B vitamins: thiamine, riboflavin, niacinamide, pantothenic acid, pyridoxine, biotin, folic acid, and methylcobalamin. It is intended to supplement vitamin intake and support processes including red-blood-cell and hemoglobin production, nervous-system function, and correction of vitamin B deficiency. ([biokindle.com](https://www.biokindle.com/products-biokindle/esvifil/))
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on ESVIFIL.